![Luke Walker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Luke Walker
Director/Board Member at
ZENTALIS PHARMACEUTICALS, INC.
Net worth: 805 536 $ as of 31/05/2026
Profile
Dr. Luke N.
Walker, MD, is a Chief Medical Officer at Umoja Biopharma, Inc., an Independent Director at Context Therapeutics, Inc. and an Independent Director at Zentalis Pharmaceuticals, Inc. He is on the Board of Directors at Context Therapeutics, Inc. and Zentalis Pharmaceuticals, Inc. Dr. Walker was previously employed as a Chief Medical Officer by Harpoon Therapeutics, Inc., a Vice President-Clinical Development by Seagen, Inc., and a Vice President-Clinical Development by CASCADIAN THERAPEUTICS INC.
He received his doctorate degree from the University of Oklahoma College of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 16/06/2026 | 201,384 ( 0.28% ) | 805 536 $ | 31/05/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Luke Walker active positions
| Companies | Position | Start |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Director/Board Member | 29/05/2024 |
| CONTEXT THERAPEUTICS INC. | Director/Board Member | 04/09/2024 |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Chief Tech/Sci/R&D Officer | 01/01/2025 |
Former positions of Luke Walker
| Companies | Position | End |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/08/2024 |
| SEAGEN INC. | Corporate Officer/Principal | 01/10/2022 |
| CASCADIAN THERAPEUTICS INC (USA) | Chief Tech/Sci/R&D Officer | 09/03/2018 |
Training of Luke Walker
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
University of Oklahoma College of Medicine
 University of Oklahoma College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immunotherapy company that develops T-cell engagers to treat cancer and other diseases | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
- Stock Market
- Insiders
- Luke Walker
